Results 21 to 30 of about 33,114 (236)

High Frequency of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes

open access: yesJournal of Diabetes Research, 2016
Aim. The aim of this study was to evaluate the incidence of diabetic ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes in 2006-2007 and 2013-2014. Method.
Agnieszka Szypowska   +5 more
doaj   +1 more source

Nurses' Performance Regarding Caring of Patient with Diabetic Ketoacidosis [PDF]

open access: yesEgyptian Journal of Health Care, 2017
Diabetic ketoacidosis is an acute, major, life-threatening complication of diabetes, may be fatal if not treated quickly and appropriately. Nurses' knowledge and practice play important roles in provision of supportive care to decrease morbidity and ...
Asmaa Said Ali   +2 more
doaj   +1 more source

Hyperlactatemia in diabetic ketoacidosis

open access: yesDiabetic Medicine, 2021
AbstractAimsThe study examined the prevalence and degree of lactate elevation in diabetic ketoacidosis, and explored which biochemical abnormalities predicted L‐lactate levels.MethodsWe reviewed episodes of diabetic ketoacidosis from 79 diabetes patients (one episode per patient).
Umesh Masharani   +4 more
openaire   +4 more sources

Severe hypokalaemia in diabetic ketoacidosis: a contributor to central pontine myelinolysis?

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2019
Hypokalaemia at presentation of diabetic ketoacidosis is uncommon as insulin deficiency and metabolic acidosis shifts potassium extracellularly. However, hypokalaemia is a recognised complication of the management of diabetic ketoacidosis as insulin ...
A Chinoy, N B Wright, M Bone, R Padidela
doaj   +1 more source

Successful Treatment of Diabetic Ketoacidosis in a Patient with Insulin Allergy and Coronavirus Disease 2019: A Case Report

open access: yesEndocrinology Research and Practice, 2022
Diabetic ketoacidosis is a frequent hyperglycemic emergency. During the coronavirus disease 2019 pandemic, researchers showed a higher prevalence of diabetic ketoacidosis and mortality compared with the preceding years.
Doğukan Şenberber   +4 more
doaj  

Recovery time of diabetic ketoacidosis in Africa: Systematic review and meta-analysis

open access: yesMetabolism Open
Background: Diabetes mellitus is a long-term metabolic disease marked by consistently elevated blood glucose levels. Diabetic ketoacidosis is the medical consequence of diabetes mellitus that has the highest attributed fatality rate.
Tadios Lidetu   +11 more
doaj   +1 more source

Clinical Profile of Diabetic Ketoacidosis: A Prospective Study in a Tertiary Care Hospital [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Background: Diabetic ketoacidosis, a well-known and major acute metabolic complication classically occurs in young patients with type 1 diabetes. However, it may occur in patients with type 2 Diabetes Mellitus too. Objective: Aim of this study was to
Pankaj Seth, Harpreet Kaur, Maneet Kaur
doaj   +1 more source

Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner

open access: yesAdvanced Science, EarlyView.
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang   +32 more
wiley   +1 more source

Autoantigen mRNA‐LNP Vaccination Drives Therapeutic Efficacy in Preclinical Models for Autoimmunity

open access: yesAdvanced Science, EarlyView.
Systemic and intramuscular delivery of autoantigen mRNA via lipid nanoparticles reprograms antigen‐presenting cells toward a mature, homeostatic state, driving antigen‐specific T cell exhaustion and providing therapeutic efficacy across autoimmune disease models.
Paulien Baeten   +30 more
wiley   +1 more source

The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study

open access: yesPharmaceuticals, 2022
Dapagliflozin was associated with an increased risk of diabetic ketoacidosis that has led to the European withdrawal of the authorization for the type 1 diabetes. However, it is still used for the treatment of type 2 diabetes.
Gabriella di Mauro   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy